Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

计划入组 7 人 · 首次发布于 2017 年 1 月 23 日

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

计划入组 3 人 · 首次发布于 2020 年 9 月 23 日

Expression of Protein Tyrosine Phosphatase 1B (PTP1B) and Body Composition Modification in Patients With Septic Shock

计划入组 52 人 · 首次发布于 2017 年 6 月 16 日

protein phosphatase 2A activators

Protein Tyrosine Phosphatase Inhibitors (Merck Canada)

protein tyrosine phosphatase 1B inhibitors (Aurigene)

Lixte Biotechnology

United States

2A Pharma AB

Sweden

Protein Sciences Corporation

United States

Lixte Biotechnology's LB-100 Shows Promise in Multiple Cancer Indications Through Novel PP2A Inhibition

Forskolin Shows Dual Mechanism Against Aggressive KMT2A-Rearranged Acute Myeloid Leukemia

PPP2R1A Mutations Linked to Better Survival in High-Risk Endometrial Cancer Patients on Immunotherapy